Venarus 1000 pills 1000mg, 60pcs

Composition

1 tablet contains:

Pharmacological action

Venarus® has an angioprotective and venotonizing effect. Reduces the extensibility of the veins, increases their tone and reduces venous congestion; reduces the permeability, fragility of capillaries and increases their resistance; improves microcirculation and lymph outflow. When used systematically, it reduces the severity of clinical manifestations of chronic venous insufficiency of the lower extremities of organic and functional nature. The optimal dose-effect ratio is observed when taking 1000 mg per day.

Indications

Venarus® is indicated for the treatment of symptoms of chronic venous diseases (elimination and relief of symptoms). Treatment of symptoms of venous-lymphatic insufficiency:

Treatment of venous-lymphatic insufficiency manifestations:

Symptomatic treatment of acute and chronic hemorrhoids.

Use during pregnancy and lactation

Pregnancy:

Breast-feeding period:

Effect on reproductive function:

Contraindications

Hypersensitivity to the active ingredients or excipients that make up the drug. It is not recommended to take the drug to women during breastfeeding.

Side effects

The frequency of adverse reactions is presented as follows: very common (≥1/10 of cases), common (≥1/100 and <1/10 of cases), infrequent (≥1/1000 and <1/100 of cases), rare (≥1/10000 and <1/1000 of cases) and very rare ( Adverse reactions, the frequency of which cannot be estimated from available data, are labeled “frequency unknown”.

If any of the adverse reactions listed in the instructions get worse, or you notice other adverse reactions not listed in the instructions, tell your doctor.

Interaction

Not noted. You should inform your doctor about all medications you are taking.

How to take, course of use and dosage

Inside.

Overdose

Cases of overdose are not described. If you overdose, seek immediate medical attention.

Description

Tablets covered with a film-coated orange-pink color, biconvex, oblong shape with rounded ends, with a risk. On a cross-section, the core is grayish-yellow to brownish-gray in color.

Functional features

The main release of the drug occurs through the intestines. On average, about 14% of the amount of the drug taken is excreted through the kidneys. The elimination half-life is 11 hours. Venarus ® undergoes an active metabolism, which is confirmed by the presence of phenolic acids in the urine.

Special instructions

Before you start taking Venarus®, it is recommended to consult your doctor.

Contact your doctor immediately if your condition worsens or does not improve during treatment.

Form of production

Film-coated tablets,1000 mg. In a package of 60 pcs., which together with the instructions for use are placed in a pack of cardboard.

Storage conditions

At a temperature not exceeding 25 C.

Shelf

life is 3 years. Do not use after the expiration date indicated on the package.

Active ingredient

Hesperidin, Diosmin

Dosage form

Tablets